Alexander Shulgin Born June 17, 1925
Nationality American Education Ph.D. from UC Berkeley in Biochemistry, post-doctoral work in the fields of psychiatry and pharmacology Occupation Psychopharmacologist Title "The Godfather of Psychedelics"  Spouse Ann Shulgin Website CaringBridge website
Shulgin is credited with the popularization of MDMA, commonly known as ecstasy, in the late 1970s and early 1980s, especially for psychopharmaceutical use and the treatment of depression and post-traumatic stress disorder. In subsequent years, Shulgin discovered, synthesized, and bioassayed over 230 psychoactive compounds. In 1991 and 1997, he and his wife Ann Shulgin authored the books PiHKAL and TiHKAL on the topic of psychoactive drugs. Shulgin discovered many noteworthy phenethylamines including the 2C* family of which 2C-T-2, 2C-T-7, 2C-E, 2C-I, and 2C-B are most well known. Additionally, Shulgin performed seminal work into the descriptive synthesis of compounds based on the organic compound tryptamine.
Life and career
Shulgin was born in Berkeley, California to Russian parents, Theodore Stevens Shulgin (1893–1978) and Henrietta D. Shulgin (1888–1960). Both Theodore and Henrietta were public school teachers in Alameda County.
Shulgin began studying organic chemistry as a Harvard University scholarship student. In 1943, at the age of 19, he dropped out of school, and joined the U.S. Navy, where he eventually became interested in pharmacology. After serving in the Navy (veteran of World War II), he returned to Berkeley, California, and in 1954 earned his Ph.D. in biochemistry from the University of California, Berkeley. Through the late 1950s, Shulgin completed post-doctoral work in the fields of psychiatry and pharmacology at University of California, San Francisco. After working at Bio-Rad Laboratories as a research director for a brief period, he began work at Dow Chemical Company as a senior research chemist.
I first explored mescaline in the late '50s, Three-hundred-fifty to 400 milligrams. I learned there was a great deal inside me.
— Alexander Shulgin, LA Times, 1995
He would later write that everything he saw and thought "had been brought about by a fraction of a gram of a white solid, but that in no way whatsoever could it be argued that these memories had been contained within the white solid ... I understood that our entire universe is contained in the mind and the spirit. We may choose not to find access to it, we may even deny its existence, but it is indeed there inside us, and there are chemicals that can catalyze its availability."
Shulgin's professional activities continued to lean in the direction of psychopharmacology, furthered by his personal experiences with psychedelics. But during this period he was unable to do much independent research. His opportunity for further research came with his development of Zectran, the first biodegradable pesticide, a highly profitable product. Dow Chemical Company, in return for Zectran's valuable patent, gave Shulgin great freedom. During this time, he created and patented drugs when Dow asked, and published findings on other drugs in journals such as Nature and the Journal of Organic Chemistry. Eventually, Dow Chemical requested that he no longer use their name on his publications.
In 1965, Shulgin left Dow to pursue his own interests, and became a private consultant, also frequently teaching classes in the local universities and at the San Francisco General Hospital. Through his friend Bob Sager, head of the U.S. DEA's Western Laboratories, Shulgin formed a relationship with the DEA and began holding pharmacology seminars for the agents, supplying the DEA with samples of various compounds, and occasionally serving as an expert witness in court. He also authored a definitive law enforcement reference book on controlled substances and received several awards from the DEA.
In recent years, Shulgin has worked on a series of N-allylated tryptamines including 5-MeO-DALT and 5-MeO-MALT. On April 8, 2008, at the age of 82, he underwent surgery to replace a defective aortic valve. On November 16, 2010, Dr. Shulgin suffered a stroke. He is expected to fully recover. In December of 2010 he suffered another stroke, followed by skin-grafting surgery to save his left foot from an amputation.
In order to carry out consulting work with the DEA, Shulgin obtained a DEA Schedule I license for an analytical laboratory, which allowed him to possess and synthesize any otherwise illicit drug. Shulgin set up a chemical synthesis laboratory in a small building behind his house, which gave him a great deal of career autonomy. Shulgin used this freedom to synthesize and test the effects of psychoactive drugs.
In 1967, Shulgin was introduced to MDMA (ecstasy) by a graduate student in the medicinal chemistry group he advised at San Francisco State University. MDMA had been synthesized in 1912 by Merck and patented in 1912 as a intermediate of another synthesis in order to block competitors, but was never explored in its own right. Shulgin went on to develop a new synthesis method, and in 1976, introduced the chemical to Leo Zeff, a psychologist from Oakland, California. Zeff used the substance in his practice in small doses as an aid to talk therapy. Zeff introduced the substance to hundreds of psychologists around the nation, including Ann Shulgin, whom Alexander Shulgin met in 1979, and married in 1981.
After judicious self-experiments, Shulgin enlisted a small group of friends with whom he regularly tested his creations, starting in 1960. They developed a systematic way of ranking the effects of the various drugs, known as the Shulgin Rating Scale, with a vocabulary to describe the visual, auditory and physical sensations. He personally tested hundreds of drugs, mainly analogues of various phenethylamines (family containing MDMA and mescaline), and tryptamines (family containing DMT and psilocybin). There are a seemingly infinite number of slight chemical variations, all of which produce variations in effect—some pleasant and some unpleasant, depending on the person, substance, and situation—all of which are meticulously recorded in Shulgin's lab notebooks. Shulgin published many of these objective and subjective reports in his books and papers.
In 1994, two years after the publication of PiHKAL, the DEA raided his lab. The agency requested that Shulgin turn over his license for violating the license's terms, and he was fined $25,000 for possession of anonymous samples sent to him for quality testing. In the 15 years preceding the publication of PiHKAL, two announced and scheduled reviews failed to find any irregularities. Richard Meyer, spokesman for DEA's San Francisco Field Division, has stated that, "It is our opinion that those books are pretty much cookbooks on how to make illegal drugs. Agents tell me that in clandestine labs that they have raided, they have found copies of those books."
- with Manning, Tania &; Daley, Paul (2011). The Shulgin Index Vol 1: Psychedelic Phenethylamines and Related Compounds. Berkeley: Transform Press. ISBN 9780963009630 .
- with Perry, Wendy (2002). The Simple Plant Isoquinolines. Berkeley: Transform Press. ISBN 0-9630096-2-1 .
- with Shulgin, Ann (1997). "A New Vocabulary". In Forte, Robert. Entheogens and the Future of Religion. Berkeley: Council on Spiritual Practices. ISBN 1-889725-01-3 .
- with Shulgin, Ann (1997). TiHKAL: The Continuation. Berkeley: Transform Press. ISBN 0-9630096-9-9 .
- with Shulgin, Ann (1991). PiHKAL: A Chemical Love Story. Berkeley: Transform Press. ISBN 0-9630096-0-5 .
- (1988). Controlled Substances: Chemical & Legal Guide to Federal Drug Laws. Berkeley: Ronin Publishing. ISBN 0-914171-50-X .
- (2011). The Shulgin Index: Psychedelic Phenethylamines and Related Compounds Volume 1. Berkeley: Transform Press. ISBN 0-963009-63-X .
Other notable publications
- 1960-1979 lab notebooks of Dr. Shulgin
- 1963. "Psychotomimetic agents related to mescaline". Experientia 19: 127. 19
- 1963. "Composition of the myristicin fraction from oil of nutmeg". Nature 197: 379. 20
- 1963. "Concerning the pharmacology of nutmeg". Mind 1: 299-302. 23
- 1964. "3-methoxy-4,5-methylenedioxy amphetamine, a new psychotomimetic agent". Nature 201: 1120-1121. 29
- 1964. "Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines". Experientia 20: 366. 30
- 1964. with H. O. Kerlinger. "Isolation of methoxyeugenol and trans-isoelemicin from oil of nutmeg". Naturwissenschaften 15: 360-361. 31
- 1965. "Synthesis of the trimethoxyphenylpropenes". Can. J. Chem. 43: 3437-3440. 43
- 1966. "Possible implication of myristicin as a psychotropic substance". Nature 210: 380-384. 45
- 1966. "The six trimethoxyphenylisopropylamines (trimethoxyamphetamines)". J. Med. Chem. 9: 445-446. 46
- 1966. with T. Sargent, and C. Naranjo. "Role of 3,4-dimethoxyphenethylamin in schizophrenia". Nature 212: 1606-1607. 48
- 1967. with T. Sargent, and C. Naranjo. "The chemistry and psychopharmacology of nutmeg and of several related phenylisopropylamines". In D. H. Efron [ed.]: Ethnopharmacologic search for psychoactive drugs. U. S. Dept. of H. E. W., Public Health Service Publication No. 1645. Pp. 202–214. Discussion: ibid. pp. 223–229. 49
- 1967. with T. Sargent. "Psychotropic phenylisopropylamines derived from apiole and dillapiole". Nature 215: 1494-1495. 50
- 1967. with Sargent, T. W., D. M. Israelstam, S. A. Landaw, and N. N. Finley. "A note concerning the fate of the 4-methoxyl group in 3,4-dimethoxyphenethylamine (DMPEA)". Biochem. Biophys. Res. Commun. 29: 126-130. 52
- 1967. with Naranjo, C. and T. Sargent. "Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy". Med. Pharmacol. Exp. 17: 359-364. 53
- 1968. "The ethyl homologs of 2,4,5-trimethoxyphenylisopropylamine". J. Med. Chem. 11: 186-187. 54
- 1969. with T. Sargent and C. Naranjo. "Structure activity relationships of one-ring psychotomimetics". Nature 221: 537-541. 57
- 1969. "Recent developments in cannabis chemistry". J. Psyched. Drugs 2: 15-29. 58
- 1969. "Psychotomimetic agents related to the catecholamines". J. Psyched. Drugs 2(2): 12-26. 59
- 1970. "Chemistry and structure-activity relationships of the psychotomimetics". In D. H. Efron [ed.]. "Psychotomimetic Drugs". Raven Press, New York. Pp. 21–41. 60
- 1970. "The mode of action of psychotomimetic drugs; some qualitative properties of the psychotomimetics". Neur. Res. Prog. Bull. 8: 72-78. 61
- 1970. "4-alkyl-dialkoxy-alpha-methyl-phenethylamines and their pharmacologically-acceptable salts". U. S. Patent 3,547,999, issued Dec. 15, 1970. 63
- 1971. with T. Sargent and C. Naranjo. "4-bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog". Pharmacology 5: 103-107. 64
- 1971. "Chemistry and sources". In S. S. Epstein [ed]. "Drugs of abuse: their genetic and other chronic nonpsychiatric hazards". The MIT Press, Cambridge, Mass. Pp 3–26. 65
- 1971. "Preliminary studies of the synthesis of nitrogen analogs of Delta1-THC". Acta Pharm. Suec. 8: 680-681. 66
- 1972. "Hallucinogens, CNS stimulants, and cannabis. In S. J. Mulé and H. Brill [eds.]: Chemical and biological aspects of drug dependence". CRC Press, Cleveland, Ohio. Pp. 163–175. 67
- 1973. "Stereospecific requirements for hallucinogenesis". J. Pharm. Pharmac. 25: 271-272. 68
- 1973. "Mescaline: the chemistry and pharmacology of its analogs". Lloydia 36: 46-58. 69
- 1973. "The narcotic pepper - the chemistry and pharmacology of Piper methysticum and related species". Bull. Narc. 25: 59-1974. "Le poivre stupéfiant - chemie et pharmacologie du Piper methysticum et des espéces apparentées". Bull. Stupéfiants 25: 61-77. 70
- 1973. with T. Sargent and C. Naranjo. "Animal pharmacology and human psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine (MMDA)". Pharmacology 10: 12-18. 71
- 1974. with Kalbhen, D. A., T. Sargent, G. Braun, H. Stauffer, N. Kusubov, and M. L. Nohr. "Human pharmacodynamics of the psychodysleptic 4-bromo-2,5-dimethoxyphenylisopropylamine labelled with Br". IRCS (Int. Res. Comm. Sys.) 2: 1091. 73
- 1975. with Sargent, T., D. A. Kalbhen, H. Stauffer, and N. Kusubov. "A potential new brain-scanning agent: 4-Br-2,5-dimethoxyphenylisopropylamine (4-Br-DPIA)". J. Nucl. Med. 16: 243-245. 74
- 1975. with M. F. Carter. "Centrally active phenethylamines". Psychopharm. Commun. 1: 93-98. 75
- 1975. with Sargent, T., D. A. Kalbhen, G. Braun, H. Stauffer, and N. Kusubov. "In vivo human pharmacodynamics of the psychodysleptic 4-Br-2,5-dimethoxyphenylisopropylamine labelled with Br or Br". Neuropharmacology 14: 165-174. 76
- 1975. "The chemical catalysis of altered states of consciousness. Altered states of consciousness, current views and research problems". The drug abuse council, Washington, D. C. Pp. 123–134. 77
- 1975. "Drug use and anti-drug legislation". The PharmChem Newsletter 4 (#8). 79
- 1975. with D. C. Dyer. "Psychotomimetic phenylisopropylamines. 5. 4-alkyl-2,5-dimethoxyphenylisopropylamines". J. Med. Chem. 18: 1201-1204. 80
- 1975. with C. Helisten. "Differentiation of PCP, TCP, and a contaminating precursor PCC, by thin layer chromatography". Microgram 8: 171-172. 81
- 1975. with Helisten, C. "The detection of 1-piperidinodydlohexanecarbonitrile contamination in illicit preparations of 1-(1-phenylcyclohexyl)piperidine and 1-(1-(2-thienyl)cyclohexyl)piperidine". J. Chrom. 117: 232-235. 82
- 1976. "Psychotomimetic agents". In M. Gordon [ed.] "Psychopharmacological agents", Vol. 4. Academic Press, New York. Pp. 59–146. 83
- 1976. "Abuse of the term 'amphetamines'". Clin. Tox. 9: 351-352. 84
- 1976. "Profiles of psychedelic drugs. 1. DMT". J. Psychedelic Drugs 8: 167-168. 85
- 1976. "Profiles of psychedelic drugs. 2. TMA-2". J. Psychedelic Drugs 8: 169. 86
- 1976. with D. E. MacLean. "Illicit synthesis of phencyclidine (PCP) and several of its analogs". Clin. Tox. 9: 553-560. 87
- 1976. with Nichols, D. E. "Sulfur analogs of psychotomimetic amines". J. Pharm. Sci. 65: 1554-1556. 89
- 1976. with Sargent, T. and N. Kusubov. "Quantitative measurement of demethylation of C-methoxyl labeled DMPEA and TMA-2 in rats". Psychopharm. Commun. 2: 199-206. 90
- 1976. with Standridge, R. T., H. G. Howell, J. A. Gylys, R. A. Partyka. "Phenylalkylamines with potential psychotherapeutic utility. 1. 2-amino-1-(2,5,-dimethoxy-4-methylphenyl)butane". J. Med. Chem. 19: 1400-1404. 91
- 1976. "Profiles of psychedelic drugs. 3. MMDA". J. Psychedelic Drugs 8: 331. 92
- 1977. "Profiles of psychedelic drugs. 4. Harmaline". J. Psychedelic Drugs 9: 79-80. 93
- 1977. "Profiles of psychedelic drugs. 5. STP". J. Psychedelic Drugs 9: 171-172. 94
- 1977. with Nichols, D. E., and D. C. Dyer. "Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives". Life Sciences 21: 569-576. 95
- 1977. with Jacob, P. III, G. Anderson III, C. K. Meshul, and N. Castagnoli Jr. "Mononethylthio analogues of 1-(2,4,5-trimethoxyphenyl)2-aminopropane". J. Med. Chem. 20: 1235-1239. 96
- ^ http://www.youtube.com/watch?v=FA8ddx_iC_g DIRTY PICTURES - Alexander Shulgin documentary movie trailer, SXSW 2010
- ^ Ancestry.com. California Birth Index, 1905-1995 [database on-line]. Provo, UT, USA: Ancestry.com Operations Inc, 2005. Original data: State of California. California Birth Index, 1905-1995. Sacramento, CA, USA: State of California Department of Health Services, Center for Health Statistics.
- ^ Ancestry.com. California Death Index, 1940-1997 [database on-line]. Provo, UT, USA: Ancestry.com Operations Inc, 2000. Original data: State of California. California Death Index, 1940–1997. Sacramento, CA, USA: State of California Department of Health Services, Center for Health Statistics.
- ^ Ancestry.com. California Death Index, 1940–1997 [database on-line]. Provo, UT, USA: Ancestry.com Operations Inc, 2000. Original data: State of California. California Death Index, 1940–1997. Sacramento, CA, USA: State of California Department of Health Services, Center for Health Statistics.
- ^ Ancestry.com. 1930 United States Federal Census [database on-line]. Provo, UT, USA: Ancestry.com Operations Inc, 2002. Year: 1930; Census Place: Berkeley, Alameda, California; Roll 111; Page: 1B; Enumeration District: 320; File: 1029.0.
- ^ a b c d e f g h i Bennett, Drake (2005-01-30). "Dr. Ecstasy". New York Times Magazine (New York Times). http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html. Retrieved 2006-07-08.
- ^ a b Romero, Dennis (1995-09-05). "Sasha Shulgin, Psychedelic Chemist". Los Angeles Times. http://www.erowid.org/culture/characters/shulgin_alexander/shulgin_alexander_interview1.shtml. Retrieved 2006-07-08.
- ^ Shulgin, Alexander (1988). Controlled Substances: Chemical & Legal Guide to Federal Drug Laws. Ronin Publishing. ISBN 0-914171-50-X.
- ^ "Vice Magazine – The Last Interview With Alexander Shulgin". http://www.viceland.com/int/v17n5/htdocs/the-last-interview-with-alexander-shulgin-423.php.
- ^ "MAPS News 6/19/2008". http://www.maps.org/sys/nq.pl?id=1610.
- ^ "Psychedelic Research - Sasha Shulgin". http://psychedelicresearch.org/?p=125.
- ^ "DEA Raid of Shulgin's Laboratory". Erowid. 2004-01-08. http://www.erowid.org/culture/characters/shulgin_alexander/shulgin_alexander_raid.shtml. Retrieved 2006-07-08.
- The Shulgin Legacy Project; a new initiative of the Alexander Shulgin Research Institute
- Matrixmasters Podcasts featuring the Shulgins
- Erowid Character Vaults : Alexander Shulgin
- His 'Ask Dr. Shulgin' Blog
- Dr. Alexander Shulgin on Twitter
- Altered Statesman
- Video: Natural origins of psychedelic drugs – Alexander Sasha Shulgin: A Chemical Performance
- Vice Magazine: The Last interview with Alexander Shulgin
Wikimedia Foundation. 2010.
Look at other dictionaries:
Alexander Shulgin — Alexander „Sasha“ Shulgin (* 17. Juni 1925 in Berkeley, Kalifornien) ist ein amerikanischer Chemiker und Pharmakologe russischer Abstammung. Er ist bekannt für seine jahrzehntelange Arbeit in der systematischen Entwicklung von synthetischen… … Deutsch Wikipedia
Alexander Shulgin — Archivo:Shulgin Alexander.jpg Alexander Shulgin Alexander Sasha Shulgin (nacido el 17 de junio de 1925 en Berkeley) es un farmacéutico, químico y promotor de drogas psicoactivas estadounidense con ascendencia rusa. Shulgin se hizo conocido tras… … Wikipedia Español
Alexander Shulgin — Alexander « Sasha » Shulgin (17 juin 1925 ) est un pharmacologue et chimiste américain. Il est connu pour la création de nouveaux produits chimiques psychoactifs. Biographie Après avoir servi dans la marine, il obtient son… … Wikipédia en Français
Alexander Shulgin (musician) — Alexander Shulgin (b. August, 25, 1964) is a Russian author and composer. He was born in Irkutsk, Russia, and currently lives in Moscow.BiographyCareerShulgin s career began at the age of 19 in Russian rock band The Cruise; the band is regarded… … Wikipedia
Shulgin — Dieser Artikel oder Abschnitt bedarf einer Überarbeitung. Näheres ist auf der Diskussionsseite angegeben. Hilf mit, ihn zu verbessern, und entferne anschließend diese Markierung. Alexander „Sasha“ Shulgin (* 17. Juni 1925 in Berkeley,… … Deutsch Wikipedia
Shulgin Rating Scale — The Shulgin Rating Scale is a simple scale for reporting the subjective effect of psychoactive substances at a given dosage, and at a given time. The system was developed for research purposes by the American biochemist Alexander Shulgin and… … Wikipedia
Shulgin — Last name Shulgin may refer to the following people: *Vasily Shulgin (1878 1976), Imperial Russian politician *Alexander Shulgin (b. 1925), American pharmacologist and drug developer *Alexei Shulgin (b. 1963), Russian contemporary artist … Wikipedia
Alexander Borodin — Infobox Scientist name =Alexander Borodin caption =Alexander Borodin birth date = birth date|1833|11|12|mf=y! birth place =Saint Petersburg residence = nationality =flag|Russia|name=Russian death date = death date and age|1887|02|27|1833|11|12… … Wikipedia
Alexander Guchkov — Alexander Ivanovich Guchkov (October 14 1862, Moscow – February 14 1936) was a Russian politician, Chairman of the Duma and Minister of War in the Russian Provisional Government.Early yearsUnlike most of conservative politicians of that time,… … Wikipedia
Shulgin, Alexander — (Sasha) (1925– ) Pharmacologist and chemist known for his work on entheogens and especially as a pioneer of psychedelic research, including the synthesis of new hallucinogenic chemicals. At the University of San Francisco, Shulgin completed… … Historical dictionary of shamanism